{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:43:19Z","timestamp":1765482199455,"version":"3.48.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,11]]},"DOI":"10.7759\/cureus.98984","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:40:28Z","timestamp":1765482028000},"source":"Crossref","is-referenced-by-count":0,"title":["Extremely Long-Term Glioblastoma Survival (Ten Years): A Possible Role of Immune Modulation From Pre-existing Diseases"],"prefix":"10.7759","author":[{"given":"Diogo","family":"Rocha Grade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e2nia","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Jo\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Marques Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm204","article-title":"Long-term survival with glioblastoma multiforme","volume":"130","author":"Krex D","year":"2007","unstructured":"Krex D, Klink B, Hartmann C, et al.. Long-term survival with glioblastoma multiforme. Brain. 2007, 130:2596-606. 10.1093\/brain\/awm204","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.05.002","article-title":"Ten-year survival in glioblastoma. A systematic review","volume":"54","author":"Tykocki T","year":"2018","unstructured":"Tykocki T, Eltayeb M. Ten-year survival in glioblastoma. A systematic review. J Clin Neurosci. 2018, 54:7-13. 10.1016\/j.jocn.2018.05.002","journal-title":"J Clin Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.05.002","article-title":"Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419)","volume":"189","author":"Hertler C","year":"2023","unstructured":"Hertler C, Felsberg J, Gramatzki D, et al.. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419). Eur J Cancer. 2023, 189:112913. 10.1016\/j.ejca.2023.05.002","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007422","article-title":"Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: a single-center analysis","volume":"96","author":"Roh TH","year":"2017","unstructured":"Roh TH, Park HH, Kang SG, et al.. Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: a single-center analysis. Medicine (Baltimore). 2017, 96:e7422. 10.1097\/MD.0000000000007422","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2021.01.103","article-title":"Analysis of factors associated with long-term survival in glioblastoma","volume":"149","author":"Madhugiri VS","year":"2021","unstructured":"Madhugiri VS, Moiyadi AV, Shetty P, et al.. Analysis of factors associated with long-term survival in glioblastoma. World Neurosurg. 2021, 149:e758-65. 10.1016\/j.wneu.2021.01.103","journal-title":"World Neurosurg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2635-1","article-title":"Long-term survivors of glioblastoma: a closer look","volume":"136","author":"Gately L","year":"2018","unstructured":"Gately L, McLachlan SA, Philip J, Ruben J, Dowling A. Long-term survivors of glioblastoma: a closer look. J Neurooncol. 2018, 136:155-62. 10.1007\/s11060-017-2635-1","journal-title":"J Neurooncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov326","article-title":"Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial","volume":"18","author":"Suchorska B","year":"2016","unstructured":"Suchorska B, Weller M, Tabatabai G, et al.. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. Neuro Oncol. 2016, 18:549-56. 10.1093\/neuonc\/nov326","journal-title":"Neuro Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3171\/2011.2.jns10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas","volume":"115","author":"Sanai N","year":"2011","unstructured":"Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011, 115:3-8. 10.3171\/2011.2.jns10998","journal-title":"J Neurosurg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2767","article-title":"Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma","volume":"9","author":"Anssar TM","year":"2020","unstructured":"Anssar TM, Leitzmann MF, Linker RA, et al.. Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma. Cancer Med. 2020, 9:1263-75. 10.1002\/cam4.2767","journal-title":"Cancer Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25027","article-title":"A rare but morbid occurrence: development of glioblastoma multiforme during tumor necrosis factor inhibitor therapy","volume":"14","author":"Kraemer LS","year":"2022","unstructured":"Kraemer LS, Humes RJ, Syed AS, Tritsch AM. A rare but morbid occurrence: development of glioblastoma multiforme during tumor necrosis factor inhibitor therapy. Cureus. 2022, 14:e25027. 10.7759\/cureus.25027","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112429","article-title":"Modulation of the immune environment in glioblastoma by the gut microbiota","volume":"12","author":"Green GB","year":"2024","unstructured":"Green GB, Cox-Holmes AN, Potier AC, Marlow GH, McFarland BC. Modulation of the immune environment in glioblastoma by the gut microbiota. Biomedicines. 2024, 12:2429. 10.3390\/biomedicines12112429","journal-title":"Biomedicines"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix233","article-title":"Aberrant humoral immune responses in neurosyphilis: CXCL13\/CXCR5 play a pivotal role for B-cell recruitment to the cerebrospinal fluid","volume":"216","author":"Yu Q","year":"2017","unstructured":"Yu Q, Cheng Y, Wang Y, et al.. Aberrant humoral immune responses in neurosyphilis: CXCL13\/CXCR5 play a pivotal role for B-cell recruitment to the cerebrospinal fluid. J Infect Dis. 2017, 216:534-44. 10.1093\/infdis\/jix233","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1201452","article-title":"Secondary immunoreaction in patients with neurosyphilis and its relevance to clinical outcomes","volume":"14","author":"Fang Y","year":"2023","unstructured":"Fang Y, Wu H, Liu G, et al.. Secondary immunoreaction in patients with neurosyphilis and its relevance to clinical outcomes. Front Neurol. 2023, 14:1201452. 10.3389\/fneur.2023.1201452","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.02.005","article-title":"Neurosyphilis is characterized by a compartmentalized and robust neuroimmune response but not by neuronal injury","volume":"5","author":"Catalano AA","year":"2024","unstructured":"Catalano AA, Yoon J, Fertuzinhos S, et al.. Neurosyphilis is characterized by a compartmentalized and robust neuroimmune response but not by neuronal injury. Med. 2024, 5:321-334.e3. 10.1016\/j.medj.2024.02.005","journal-title":"Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.615434","article-title":"Case report: microglia composition and immune response in an immunocompetent patient with an intracranial syphilitic Gumma","volume":"11","author":"Yu Q","year":"2020","unstructured":"Yu Q, Li W, Mo X, Tan F, Yang L. Case report: microglia composition and immune response in an immunocompetent patient with an intracranial syphilitic Gumma. Front Neurol. 2020, 11:615434. 10.3389\/fneur.2020.615434","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1753425920952840","article-title":"Syphilitic infection impairs immunity by inducing both apoptosis and pyroptosis of CD4(+) and CD8(+) T lymphocytes","volume":"27","author":"Xia W","year":"2021","unstructured":"Xia W, Zhao J, Su B, et al.. Syphilitic infection impairs immunity by inducing both apoptosis and pyroptosis of CD4(+) and CD8(+) T lymphocytes. Innate Immun. 2021, 27:99-106. 10.1177\/1753425920952840","journal-title":"Innate Immun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1141034","article-title":"Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions","volume":"13","author":"Liu J","year":"2023","unstructured":"Liu J, Piranlioglu R, Ye F, Shu K, Lei T, Nakashima H. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions. Front Cell Infect Microbiol. 2023, 13:1141034. 10.3389\/fcimb.2023.1141034","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428058-extremely-long-term-glioblastoma-survival-ten-years-a-possible-role-of-immune-modulation-from-pre-existing-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T19:40:29Z","timestamp":1765482029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428058-extremely-long-term-glioblastoma-survival-ten-years-a-possible-role-of-immune-modulation-from-pre-existing-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.98984","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}